These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35205914)

  • 1. Association of COVID-19-Associated Pulmonary Aspergillosis with Cytomegalovirus Replication: A Case-Control Study.
    Calderón-Parra J; Moreno-Torres V; Mills-Sanchez P; Tejado-Bravo S; Romero-Sánchez I; Balandin-Moreno B; Calvo-Salvador M; Portero-Azorín F; García-Masedo S; Muñez-Rubio E; Ramos-Martinez A; Fernández-Cruz A
    J Fungi (Basel); 2022 Feb; 8(2):. PubMed ID: 35205914
    [No Abstract]   [Full Text] [Related]  

  • 2. Association between Pulmonary Aspergillosis and
    Caciagli V; Coloretti I; Talamonti M; Farinelli C; Gatto I; Biagioni E; Sarti M; Franceschini E; Meschiari M; Mussini C; Tonelli R; Clini E; Girardis M; Busani S; Modena Covid-Working Group
    Viruses; 2023 Nov; 15(11):. PubMed ID: 38005936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19-associated pulmonary aspergillosis (CAPA): Risk factors and development of a predictive score for critically ill COVID-19 patients.
    Calderón-Parra J; Mills-Sanchez P; Moreno-Torres V; Tejado-Bravo S; Romero-Sánchez I; Balandin-Moreno B; Calvo-Salvador M; Portero-Azorín F; García-Masedo S; Muñez-Rubio E; Ramos-Martinez A; Fernández-Cruz A;
    Mycoses; 2022 May; 65(5):541-550. PubMed ID: 35212030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology.
    Prattes J; Wauters J; Giacobbe DR; Salmanton-García J; Maertens J; Bourgeois M; Reynders M; Rutsaert L; Van Regenmortel N; Lormans P; Feys S; Reisinger AC; Cornely OA; Lahmer T; Valerio M; Delhaes L; Jabeen K; Steinmann J; Chamula M; Bassetti M; Hatzl S; Rautemaa-Richardson R; Koehler P; Lagrou K; Hoenigl M;
    Clin Microbiol Infect; 2022 Apr; 28(4):580-587. PubMed ID: 34454093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A screening study for COVID-19-associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic.
    Er B; Er AG; Gülmez D; Şahin TK; Halaçlı B; Durhan G; Ersoy EO; Alp A; Metan G; Saribas Z; Arikan-Akdagli S; Hazırolan G; Akıncı SB; Arıyürek M; Topeli A; Uzun Ö
    Mycoses; 2022 Jul; 65(7):724-732. PubMed ID: 35531631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Burden of COVID-19-Associated Pulmonary Aspergillosis in Severely Immunocompromised Patients Requiring Mechanical Ventilation.
    Feys S; Lagrou K; Lauwers HM; Haenen K; Jacobs C; Brusselmans M; Debaveye Y; Hermans G; Hoenigl M; Maertens J; Meersseman P; Peetermans M; Spriet I; Vandenbriele C; Vanderbeke L; Vos R; Van Wijngaerden E; Wilmer A; Wauters J
    Clin Infect Dis; 2024 Feb; 78(2):361-370. PubMed ID: 37691392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspergillus Test Profiles and Mortality in Critically Ill COVID-19 Patients.
    Ergün M; Brüggemann RJM; Alanio A; Dellière S; van Arkel A; Bentvelsen RG; Rijpstra T; van der Sar-van der Brugge S; Lagrou K; Janssen NAF; Buil JB; van Dijk K; Melchers WJG; Reijers MHE; Schouten JA; Wauters J; Cordey A; Soni S; White PL; van de Veerdonk FL; Verweij PE
    J Clin Microbiol; 2021 Nov; 59(12):e0122921. PubMed ID: 34495710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variants.
    Bay P; Audureau E; Préau S; Favory R; Guigon A; Heming N; Gault E; Pham T; Chaghouri A; Turpin M; Morand-Joubert L; Jochmans S; Pitsch A; Meireles S; Contou D; Henry A; Joseph A; Chaix ML; Uhel F; Roux D; Descamps D; Emery M; Garcia-Sanchez C; Levy D; Burrel S; Mayaux J; Kimmoun A; Hartard C; Pène F; Rozenberg F; Gaudry S; Brichler S; Guillon A; Handala L; Tamion F; Moisan A; Daix T; Hantz S; Delamaire F; Thibault V; Souweine B; Henquell C; Picard L; Botterel F; Rodriguez C; Dessap AM; Pawlotsky JM; Fourati S; de Prost N;
    Ann Intensive Care; 2024 Apr; 14(1):65. PubMed ID: 38658426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Covid-19-associated pulmonary aspergillosis in mechanically ventilated patients: incidence and outcome in a French multicenter observational cohort (APICOVID).
    Desmedt L; Raymond M; Le Thuaut A; Asfar P; Darreau C; Reizine F; Colin G; Auchabie J; Lorber J; La Combe B; Kergoat P; Hourmant B; Delbove A; Frérou A; Morin J; Ergreteau PY; Seguin P; Martin M; Reignier J; Lascarrou JB; Canet E
    Ann Intensive Care; 2024 Jan; 14(1):17. PubMed ID: 38285382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of Aspergillus spp. isolation in defining cases of COVID-19 Associated Pulmonary Aspergillosis - CAPA.
    Cocio TA; Siqueira LPM; Riciluca KCT; Gimenes VMF; de Andrade TS; Benard G; Martínez R; Bollela VR
    Braz J Infect Dis; 2023; 27(4):102793. PubMed ID: 37507102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cumulative steroid dose in hospitalized patients and COVID-19-associated pulmonary aspergillosis.
    Ramonfaur D; Salto-Quintana JN; Aguirre-García GM; Hernández-Mata NM; Villanueva-Lozano H; Torre-Amione G; Martínez-Reséndez MF
    J Hosp Infect; 2023 Dec; 142():26-31. PubMed ID: 37499762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lateral flow assay (LFA) in the diagnosis of COVID-19-associated pulmonary aspergillosis (CAPA): a single-center experience.
    Serin I; Baltali S; Cinli TA; Goze H; Demir B; Yokus O
    BMC Infect Dis; 2022 Nov; 22(1):822. PubMed ID: 36348480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19-Associated Pulmonary Aspergillosis in Russia.
    Shadrivova O; Gusev D; Vashukova M; Lobzin D; Gusarov V; Zamyatin M; Zavrazhnov A; Mitichkin M; Borzova Y; Kozlova O; Desyatik E; Burygina E; Ignatyeva S; Oganesyan E; Vasilyeva N; Klimko N; Working Group
    J Fungi (Basel); 2021 Dec; 7(12):. PubMed ID: 34947041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave.
    Bentvelsen RG; Arkel ALEV; Rijpstra TA; Kant MKM; Brugge SVS; Loth DW; Van Wijngaarden P; Mée AWFD; Yick DCY; Diederen BMW; Wever PC; Leenders ACAP; Van Dommelen L; Groot KH; Van den Bijllaardt W; Verweij PE
    J Fungi (Basel); 2022 Jan; 8(2):. PubMed ID: 35205851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors for Coronavirus Disease 2019 (COVID-19)-Associated Pulmonary Aspergillosis in Critically Ill Patients: A Nationwide, Multicenter, Retrospective Cohort Study.
    Kim SH; Hong JY; Bae S; Lee H; Wi YM; Ko JH; Kim B; Joo EJ; Seok H; Shi HJ; Yoo JR; Hyun M; Kim HA; Jang S; Mun SJ; Kim J; Kim MC; Jung DS; Kim SH; Peck KR
    J Korean Med Sci; 2022 May; 37(18):e134. PubMed ID: 35535369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19-associated invasive pulmonary aspergillosis in a tertiary care center in Mexico City.
    Vélez Pintado M; Camiro-Zúñiga A; Aguilar Soto M; Cuenca D; Mercado M; Crabtree-Ramirez B;
    Med Mycol; 2021 Jul; 59(8):828-833. PubMed ID: 33724423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study.
    Bartoletti M; Pascale R; Cricca M; Rinaldi M; Maccaro A; Bussini L; Fornaro G; Tonetti T; Pizzilli G; Francalanci E; Giuntoli L; Rubin A; Moroni A; Ambretti S; Trapani F; Vatamanu O; Ranieri VM; Castelli A; Baiocchi M; Lewis R; Giannella M; Viale P;
    Clin Infect Dis; 2021 Dec; 73(11):e3606-e3614. PubMed ID: 32719848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study.
    Hatzl S; Reisinger AC; Posch F; Prattes J; Stradner M; Pilz S; Eller P; Schoerghuber M; Toller W; Gorkiewicz G; Metnitz P; Rief M; Prüller F; Rosenkranz AR; Valentin T; Krause R; Hoenigl M; Schilcher G
    Crit Care; 2021 Sep; 25(1):335. PubMed ID: 34526087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, risk factors and pre-emptive screening for COVID-19 associated pulmonary aspergillosis in an era of immunomodulant therapy.
    van Grootveld R; van der Beek MT; Janssen NAF; Ergün M; van Dijk K; Bethlehem C; Stads S; van Paassen J; Heunks LMA; Bouman CSC; Reijers MHE; Brüggeman RJ; van de Veerdonk FL; van Bree SHW; van den Berg CHSB; Kuindersma M; Wauters J; Beishuizen A; Verweij PE; Schouten JA;
    J Crit Care; 2023 Aug; 76():154272. PubMed ID: 36801598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metagenomic Next-Generation Sequencing of Plasma for Diagnosis of COVID-19-Associated Pulmonary Aspergillosis.
    Hoenigl M; Egger M; Price J; Krause R; Prattes J; White PL
    J Clin Microbiol; 2023 Mar; 61(3):e0185922. PubMed ID: 36809121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.